These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25697821)

  • 1. Extending P450 site-of-metabolism models with region-resolution data.
    Zaretzki JM; Browning MR; Hughes TB; Swamidass SJ
    Bioinformatics; 2015 Jun; 31(12):1966-73. PubMed ID: 25697821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XenoSite server: a web-available site of metabolism prediction tool.
    Matlock MK; Hughes TB; Swamidass SJ
    Bioinformatics; 2015 Apr; 31(7):1136-7. PubMed ID: 25411327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks.
    Zaretzki J; Matlock M; Swamidass SJ
    J Chem Inf Model; 2013 Dec; 53(12):3373-83. PubMed ID: 24224933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOMP: web server for in silico prediction of sites of metabolism for drug-like compounds.
    Rudik A; Dmitriev A; Lagunin A; Filimonov D; Poroikov V
    Bioinformatics; 2015 Jun; 31(12):2046-8. PubMed ID: 25777527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Prediction of CYP-Mediated Metabolism with Chemical Fingerprints.
    Zaretzki J; Boehm KM; Swamidass SJ
    J Chem Inf Model; 2015 May; 55(5):972-82. PubMed ID: 25871613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alignment-Based Prediction of Sites of Metabolism.
    de Bruyn Kops C; Friedrich NO; Kirchmair J
    J Chem Inf Model; 2017 Jun; 57(6):1258-1264. PubMed ID: 28520411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism site prediction based on xenobiotic structural formulas and PASS prediction algorithm.
    Rudik AV; Dmitriev AV; Lagunin AA; Filimonov DA; Poroikov VV
    J Chem Inf Model; 2014 Feb; 54(2):498-507. PubMed ID: 24417355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple model predicts UGT-mediated metabolism.
    Dang NL; Hughes TB; Krishnamurthy V; Swamidass SJ
    Bioinformatics; 2016 Oct; 32(20):3183-3189. PubMed ID: 27324196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms.
    Kirchmair J; Williamson MJ; Tyzack JD; Tan L; Bond PJ; Bender A; Glen RC
    J Chem Inf Model; 2012 Mar; 52(3):617-48. PubMed ID: 22339582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P450 structures and oxidative metabolism of xenobiotics.
    Lewis DF
    Pharmacogenomics; 2003 Jul; 4(4):387-95. PubMed ID: 12831319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational identification and binding analysis of orphan human cytochrome P450 4X1 enzyme with substrates.
    Kumar S
    BMC Res Notes; 2015 Jan; 8():9. PubMed ID: 25595103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1.
    Foti RS; Isoherranen N; Zelter A; Dickmann LJ; Buttrick BR; Diaz P; Douguet D
    J Pharmacol Exp Ther; 2016 May; 357(2):281-92. PubMed ID: 26937021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
    Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
    J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.
    de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM
    Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based inactivation of human cytochromes p450s: experimental characterization, reactive intermediates, and clinical implications.
    Hollenberg PF; Kent UM; Bumpus NN
    Chem Res Toxicol; 2008 Jan; 21(1):189-205. PubMed ID: 18052110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FAME 2: Simple and Effective Machine Learning Model of Cytochrome P450 Regioselectivity.
    Šícho M; de Bruyn Kops C; Stork C; Svozil D; Kirchmair J
    J Chem Inf Model; 2017 Aug; 57(8):1832-1846. PubMed ID: 28782945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pragmatic approach using first-principle methods to address site of metabolism with implications for reactive metabolite formation.
    Hsiao YW; Petersson C; Svensson MA; Norinder U
    J Chem Inf Model; 2012 Mar; 52(3):686-95. PubMed ID: 22299574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenases.
    Johnson EF; Stout CD
    Biochem Biophys Res Commun; 2005 Dec; 338(1):331-6. PubMed ID: 16157296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward Computational Understanding of Molecular Recognition in the Human Metabolizing Cytochrome P450s.
    Kontoyianni M; Lacy B
    Curr Med Chem; 2018; 25(28):3353-3373. PubMed ID: 29484977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.